Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Edwards Lifesciences stock

Learn how to easily invest in Edwards Lifesciences stock.

Edwards Lifesciences is a medical devices business based in the US. Edwards Lifesciences shares (EW) are listed on the NYSE and all prices are listed in US Dollars. Edwards Lifesciences employs 15,700 staff and has a trailing 12-month revenue of around $5.4 billion.

How to buy Edwards Lifesciences stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – EW. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Edwards Lifesciences stock price (NYSE: EW)

Use our graph to track the performance of EW stocks over time.

Edwards Lifesciences shares at a glance

Information last updated 2023-01-25.
Latest market close$76.70
52-week range$67.13 - $131.10
50-day moving average $75.28
200-day moving average $90.77
Wall St. target price$91.09
PE ratio 33.2177
Dividend yield $0 (0%)
Earnings per share (TTM) $2.32

Buy Edwards Lifesciences stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Edwards Lifesciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Edwards Lifesciences price performance over time

Historical closes compared with the close of $76.7 from 2023-01-31

1 week (2023-01-25) -1.27%
1 month (2022-12-30) 2.80%
3 months (2022-11-01) 5.66%
6 months (2022-08-01) -22.88%
1 year (2022-01-28) -26.86%
2 years (2021-02-01) -6.37%
3 years (2020-01-31) 219.86
5 years (2018-02-01) 126.98

Is Edwards Lifesciences stock undervalued or overvalued?

Valuing Edwards Lifesciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Edwards Lifesciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Edwards Lifesciences's P/E ratio

Edwards Lifesciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, Edwards Lifesciences shares trade at around 33x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Edwards Lifesciences's PEG ratio

Edwards Lifesciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.0653. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Edwards Lifesciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Edwards Lifesciences's EBITDA

Edwards Lifesciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.8 billion.

The EBITDA is a measure of a Edwards Lifesciences's overall financial performance and is widely used to measure a its profitability.

Edwards Lifesciences financials

Revenue TTM $5.4 billion
Operating margin TTM 31.82%
Gross profit TTM $4 billion
Return on assets TTM 12.7%
Return on equity TTM 2481.14%
Profit margin 27.2%
Book value $10.04
Market capitalisation $49.5 billion

TTM: trailing 12 months

Edwards Lifesciences's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Edwards Lifesciences.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Edwards Lifesciences's total ESG risk score

Total ESG risk: 21.68

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Edwards Lifesciences's overall score of 21.68 (as at 12/31/2018) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Edwards Lifesciences is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Edwards Lifesciences's environmental score

Environmental score: 4.78/100

Edwards Lifesciences's environmental score of 4.78 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Edwards Lifesciences's social score

Social score: 13.43/100

Edwards Lifesciences's social score of 13.43 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Edwards Lifesciences's governance score

Governance score: 10.96/100

Edwards Lifesciences's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Edwards Lifesciences is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Edwards Lifesciences's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Edwards Lifesciences scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Edwards Lifesciences has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Edwards Lifesciences Corp was last rated for ESG on: 2019-01-01.

Total ESG score 21.68
Total ESG percentile 24.1
Environmental score 4.78
Environmental score percentile 6
Social score 13.43
Social score percentile 6
Governance score 10.96
Governance score percentile 6
Level of controversy 2

Edwards Lifesciences share dividends

We're not expecting Edwards Lifesciences to pay a dividend over the next 12 months.

Have Edwards Lifesciences's shares ever split?

Edwards Lifesciences's shares were split on a 3:1 basis on 31 May 2020. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Edwards Lifesciences shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Edwards Lifesciences shares which in turn could have impacted Edwards Lifesciences's share price.

Edwards Lifesciences share price volatility

Over the last 12 months, Edwards Lifesciences's shares have ranged in value from as little as $67.13 up to $131.1. A popular way to gauge a stock's volatility is its "beta".

EW.US volatility(beta: 1.01)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Edwards Lifesciences's is 1.008. This would suggest that Edwards Lifesciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Edwards Lifesciences overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Frequently asked questions

What percentage of Edwards Lifesciences is owned by insiders or institutions?
Currently 0.813% of Edwards Lifesciences shares are held by insiders and 85.052% by institutions.
How many people work for Edwards Lifesciences?
Latest data suggests 15,700 work at Edwards Lifesciences.
When does the fiscal year end for Edwards Lifesciences?
Edwards Lifesciences's fiscal year ends in December.
Where is Edwards Lifesciences based?
Edwards Lifesciences's address is: One Edwards Way, Irvine, CA, United States, 92614
What is Edwards Lifesciences's ISIN number?
Edwards Lifesciences's international securities identification number is: US28176E1082
What is Edwards Lifesciences's CUSIP number?
Edwards Lifesciences's Committee on Uniform Securities Identification Procedures number is: 28176E108

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site